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Abstract
Elevation of blood glucose results in increased glucose in the fluid that lines the surface of the airways and this is asso-
ciated with an increased susceptibility to infection with respiratory pathogens. Infection induces an inflammatory response 
in the lung, but how this is altered by hyperglycemia and how this affects glucose, lactate and cytokine concentrations in the 
airway surface liquid is not understood. We used Wild Type (WT) and glucokinase heterozygote (GK+/-) mice to investigate 
the effect of hyperglycemia, with and without LPS-induced inflammatory responses, on airway glucose, lactate, inflamma-
tory cells and cytokines measured in Bronchoalveolar Lavage Fluid (BALF).
We found that glucose and lactate concentrations in BALF were elevated in GK+/- compared to WT mice and that 
there was a direct correlation between blood glucose and BALF glucose concentrations. LPS challenge increased BALF 
inflammatory cell numbers and this correlated with decreased glucose and increased lactate concentrations although the 
effect was less in GK+/- compared to WT mice. All cytokines measured (except IL-2) increased in BALF with LPS chal-
lenge. However, concentrations of TNFα, INFγ, IL-1β and IL-2 were less in GK+/- compared to WT mice. This study shows 
that the normal glucose/lactate environment of the airway surface liquid is altered by hyperglycemia and the inflammatory 
response. These data indicate that inflammatory cells utilize BALF glucose and that production of lactate and cytokines is 
compromised in hyperglycemic GK+/- mice.
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Abbreviations
WT  : Wild Type
GK  : Glucokinase
ASL  : Airway Surface Liquid 
BAL  : Bronchoalveolar Lavage
BALF  : Bronchoalveolar Lavage Fluid
LPS  : Lipopolysaccharide
TNF  : Tumor Necrosis Factor
INF  : Interferon
IL  : Interleukin
PBS  : Phosphate Buffered Saline
MSD  : MesoScale Discovery
WBC  : White Blood Cells
COPD  : Chronic Obstructive Disease
CF  : Cystic Fibrosis
Introduction
There is mounting evidence that raised blood glucose concen-
trations (hyperglycemia) as a result of diabetes mellitus or severe 
illness (stress hyperglycemia) are associated with increased sus-
ceptibility to respiratory infections, particularly when associated 
with underlying respiratory disease[1-4]. Glucose concentration in 
the fluid that lines the luminal surface of the airways (airway sur-
face liquid, ASL) is in normal situations low at ~0.4mM. However, 
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we have shown that elevation of blood glucose leads to increased 
glucose concentration in ASL (up to ~4.0mM) in nasal and bron-
chial secretions in patients[1,3,5,6]. Glucose was also elevated in 
Bronchoalveolar Lavage Fluid (BALF) from the lungs of a mouse 
model of diabetes (the leptin receptor deficient db/db mouse) com-
pared to wild type[7]. Elevation of glucose was associated with 
increased Staphylococcus aureus and Pseudomonas aeruginosa 
in the airway and we have shown that sugars in the ASL can be 
utilized by these bacteria as a nutrient source for growth[8-10].
Inflammatory stimuli increase the permeability of the epi-
thelium to glucose, elevating glucose diffusion from blood into 
the ASL[9]. Inflammatory stimuli also increase activation and 
genesis of inflammatory cells and their recruitment to the airway 
lumen[7,11]. Thus, glucose in the ASL potentially supplies a lo-
cal nutrient source for inflammatory cells of the respiratory tract. 
Hyperglycemia has also been shown to modify inflammatory re-
sponses in the lung[12,13]. We hypothesized that the availability 
of glucose in the ASL and its metabolism by inflammatory cells 
could contribute to this effect. In addition, if inflammatory cells 
utilize glucose this would reduce glucose concentration in ASL 
and affect the concentration of other metabolites such as lactate.
Here, we investigated the relationship between blood glu-
cose and glucose concentration in the BALFs of normal (WT) and 
hyperglycemic (glucokinase deficient, GK+/-) mice and studied 
how this relationship, the concentration of lactate, production of 
cytokines and the inflammatory responses changed when the lungs 
were challenged with bacterial lipopolysaccharide.
Materials and Methods
Male and female (17 weeks old, average weight 24±3g) 
heterozygote GK+/- mice on C57/Bl6 background and wild type 
C57/Bl6 mice were used in the study[14]. Animals were kept in 
a facility with 12h light/dark cycle at 21±2°C and with 55±15% 
relative humidity. Water and normal rodent chow were available 
ad libitum.
WT and GK+/- mice were randomized into treatment groups 
of 4, 24 and 48 hours’ post LPS challenge versus no challenge 
(indicated as time 0) using 4-5 animals per group. Experiments 
were repeated for 0 and 48 hours to obtain additional samples for 
cytokine analysis and results from these studies were pooled. LPS 
from P.aeruginosa (Sigma-Aldrich, USA) was previously frozen 
in 1mg/ml aliquots and diluted to the concentration needed to give 
0.0875μg/g mouse in 50μl (based on the average weight of the 
group) and given by intranasal dosing at time 0. In brief, animals 
were anaesthetized with isoflurane 4-5% (O2 1.2l/min) prior to ad-
ministration of the LPS solution to one nostril, which was subse-
quently inhaled naturally. Mice were then returned to their cages 
when retaining consciousness. 
Body weight was recorded once daily from 0-48 hours af-
ter administration of LPS to follow the wellbeing of the animals. 
Blood was collected from the vena saphena in conscious mice for 
glucose evaluation after 4 hours of fasting. At 4, 24 or 48 hours af-
ter LPS administration, the animals were terminated with an over-
dose of pentobarbital (0.2ml of 100mg/ml i.p.). The lungs of each 
animal were subjected to Bronchoalveolar Lavage (BAL). In brief, 
the trachea was exposed and a catheter inserted into the trachea 
through a cut between two upper cartilage rings below the larynx. 
The catheter was secured with a silk suture and three volumes of 
0.3ml saline were instilled, gently aspirated, pooled and weighed.
The BAL fluid (BALF) was centrifuged (SorvallRotanta 
46R, HettichZentrifugen, Tullingen, Germany, 1200rpm (314g), 
10min, 4°C). The pellet was re-suspended in 0.25ml of PBS and 
the total and differential cell count was performed using SYSMEX 
XT-1800i Vet. (SYSMEX, Kobe Japan). Cell count is expressed 
as the amount of cells per ml of recovered BALF. The supernatant 
was used to measure glucose and lactate on the ABX Pentra 400 
(Horiba ABX Medical, Kyoto, Japan) according to the manufac-
turer’s protocol. Inflammatory cytokines in the supernatant were 
analyzed by means of an MSD 10-plex (K15048D-1 MSD mouse 
Pro inflammatory panel (V-plex), Mesoscale Discovery, Maryland, 
US). At termination, blood from behind the eye was collected in 
EDTA tubes and blood glucose was measured directly using Accu-
check (Roche, Bromma, Sweden). Plasma lactate was assayed us-
ing theABX Pentra 400. All experiments were approved by the 
local Ethical committee in Gothenburg (184-2012).
Statistical Analysis
Values are reported as the mean±SEM. Statistical analysis 
was performed using analysis of variance (ANOVA) tests fol-
lowed by Bonferroni multiple comparison post hoc tests (Graph-
Pad Prism) or Student’st test. P values of <0.05 were considered 
statistically significant. 
Results
Characterization of Airway Glucose Metabolism
Fasting blood glucose was higher in GK+/- than Wild Type 
(WT) mice (15.2±4.9 compared to 9.4±0.19mM, p<0.0001, n=25) 
(Figure 1a). Blood glucose remained higher in GK+/- mice com-
pared to WT 48 hours after treatment with LPS although the con-
centration of glucose was reduced to 11.7±0.6 and 7.7±0.2mM, 
respectively (p<0.0001, n=17). There was no significant difference 
in plasma insulin levels between WT and GK+/- mice (0.59±0.12 
and 0.47±0.1ng/ml, respectively, n=9). There were also no signifi-
cant changes in blood lactate concentration in WT or GK+/- at any 
of the time points tested (Figure 1b).
Glucose concentration in the BALF of GK+/- mice was sig-
nificantly higher than that of WT mice (0.15±0.2 compared to 
0.03±0.004mM, p<0.0001, n=19). It remained higher in the GK+/- 
mice following LPS challenge, but at significantly lower levels for 
both mouse types (p<0.001 at 24 and 48 hours, n=4 and 14, respec-
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tively). We could not detect any measurable glucose in BALF from 
WT mice at 24 hours (Figure 1c). There was a significant relation-
ship between blood glucose/BALF glucose concentration prior to 
treatment with LPS and independent of mouse type (p<0.0001, 
n=44). However, this relationship was lost 48 hours after treatment 
with LPS (p<0.05, F=6, Df=73) (Figure 2a).
Lactate concentration in the BALF of GK+/- mice was signifi-
cantly higher than WT in the absence of an inflammatory stimu-
lus (0.1±0.008 compared to 0.07±0.007mM, p<0.05, n=19) (Fig-
ure1d). As expected, the concentration of lactate in the BALFs of 
GK+/- and WT mice increased after treatment with LPS. Less so in 
the GK+/- mice, only reaching significance after 48 hours (p<0.01, 
n=16), whereas lactate concentration was significantly increased 
at 24 and 48 hours in WT mice (p<0.0001, n=3 and n=16, respec-
tively). There were also higher concentrations of lactate in WT 
compared to GK+/- mice at 48 hours (p<0.01, n=15) whereas the 
difference at 24 hours was borderline significant (p=0.059, n=4). 
Thus, less lactate was produced in the lungs of GK+/- mice after an 
inflammatory stimulus than in WT mice (Figure 1d).
Figure 1: Blood glucose (a), blood lactate (b), BALF glucose (c) and 
BALF lactate (d) concentrations in wild type (WT) (open symbols) and 
hyperglycaemic GK+/- mice (black symbols) before (circles) and after 
treatment with LPS for 4 (triangles), 24 (inverted triangles) and 48 hours 
(squares).  Data are shown as individual measurements.  Horizontal bars 
show mean±SEM.  Significantly different from untreated WT control, 
*p<0.05, significantly different from WT at similar time point, †p<0.05, 
significantly different from GK, + p<0.05.
There was no relationship between blood lactate and BALF 
lactate but there was a small positive relationship between blood 
glucose and BALF lactate (p<0.01, n=41) at baseline (Figure 2b). 
This relationship was completely reversed 48 hours after treat-
ment with LPS where lactate in the BALF decreased with increas-
ing blood glucose (p<0.01, n=29) (Figure 2b), similarly for both 
mouse types.
Figure 2: Relationship between blood glucose and BALF glucose (a), 
blood glucose and BALF lactate (b), before (circles) and 48 hours after 
LPS treatment (squares) in WT (open) and GK+/- (black), respectively. 
Linear regression of the points before LPS treatment (-LPS)is shown as a 
solid black line and after LPS treatment (+LPS 48h)as a broken line. Re-
lationship between total WBC measured in BALF and BALF glucose (c), 
total WBC in BALF and BALF lactate (d) before (circles) and 48 hours 
after LPS treatment (squares) in WT (open) and GK+/- (black), respec-
tively.  Linear regression of the points from WT are shown as a solid line 
and GK+/- as a broken line.
Impact of Hyperglycemia on Airway Response to Li-
popolysaccharide
Prior to LPS treatment, GK+/- mice had similar numbers of 
inflammatory cells (total White Blood Cells (WBC) including 
lymphocytes, macrophages, neutrophils and eosinophils) in the 
BALF as compared to WT. Treatment of GK+/- with LPS elicited 
an increase in inflammatory cells recovered from the BAL which 
was maximal at 24-48 hours. The absolute numbers of lympho-
cytes and neutrophils were similarly increased in WT and GK+/- at 
4, 24 and 48 hours versus untreated controls. Macrophages in the 
BALF were not elevated until 24 hours’ post LPS treatment and 
to a similar extent in WT and GK+/- mice (Figure 3a-c). Interest-
ingly, 24 hours’ post LPS treatment, eosinophils were significantly 
reduced in GK+/- compared to WT mice (p<0.01, n=3) indicating 
that the elevation of blood glucose in these mice could influence 
eosinophil recruitment and/or survival (Figure 3d).
There was a negative correlation of WBC with BALF glu-
cose in WT and GK+/- mice (p<0.05, n=40 and p<0.001, n=47, 
respectively) (Figure 2c). As white blood cell number increased, 
glucose in the BALF decreased and this was more pronounced in 
GK+/- mice. As expected, the number of WBC positively correlated 
with BALF lactate concentration, similarly in WT and GK+/- mice 
(p<0.05, n=41 and p<0.01, n=48, respectively) (Figure 2d). We 
found similar relationships with macrophages and neutrophils, the 
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most numerous cells in BALF, indicating that these were the main 
source of lactate. There was an indication that the slope of the line 
was reduced and that less lactate was produced by the inflammato-
ry cells in GK+/- compared to WT mice, however, we were unable 
to attribute significance to this observation (p=0.08). Interestingly, 
eosinophils in WT mice showed a positive association with lactate 
(p<0.0001, n=39) but this was not observed in GK+/- mice (Figure 
1d and Figure 3d).
Figure 3: Numbers of lymphocytes (a), neutrophils (b), macrophages 
(c) and eosinophils (d) in BALF from wild type (WT) (white symbols) 
and hyperglycaemic GK+/- mice (black symbols) before (circles) and after 
treatment with LPS for 4 (triangles), 24 (inverted triangles) and 48 hours 
(squares).  Data are shown as individual measurements.  Horizontal bars 
show mean±SEM.  Significantly different from untreated control, *p<0.05. 
Significantly different from WT at similar time point, †p<0.05.
Hyperglycemic Airways and Secretion of Cytokines in 
Response to Respiratory Challenge
As the greatest differences in the parameters tested were 
identified at 48 hours’ post LPS challenge, we then investigated 
cytokine concentration in the BALFs of challenged and unchal-
lenged animals. There was almost no production of cytokines into 
the BALF of untreated WT and GK+/- mice, consistent with the 
lack of inflammatory cells. LPS challenge for 48 hours signifi-
cantly increased the concentration of TNFα, IL-1β, IL-6, IL-8 and 
INFγ(Figure 4a-f). IL-2 concentrations were lower than other cy-
tokines and showed no elevation with LPS treatment (Figure 4d). 
There was significantly less IL-2, IL-1β and TNFα in the BALFs of 
GK+/- compared to WT mice 48 hours after LPS treatment (p<0.01, 
n=8-10 respectively).
Figure 4: Concentration of cytokines, TNFα(a), INFγ(b), IL-1β(c), IL-2 
(d), IL-6 (e) and IL-8 (f) present in BALF from wild type (WT) (white 
symbols) and hyperglycaemic GK+/- mice (black symbols) before (cir-
cles) and after treatment with LPS for 48 hours (squares).  Data are shown 
as individual measurements.  Horizontal bars show mean±SEM.  Signifi-
cantly different from untreated control, *p<0.05.  Significantly different 
from WT at similar time point, †p<0.05.
Discussion
The present study demonstrates increased respiratory glu-
cose concentration in a further hyperglycemic mouse model of 
human diabetes, in line with previous reports including human 
disease[1,3,7,10,15]. Also, here, we show a positive and significant 
correlation of airway glucose levels with increasing blood glucose 
concentrations, but no impact on inflammatory cells or cytokine 
release in the unchallenged situation. Exposure to Lipopolysac-
charide (LPS) completely changes the blood/BALF glucose rela-
tionship. Glucose concentration falls and lactate rises as inflam-
matory cell numbers increase. We propose that inflammatory cells 
utilize the available glucose and increase the production of lactate. 
This effect is altered with hyperglycemia. Lactate concentration is 
lower and goes in hand with less cytokine production and recruit-
ment of eosinophils. These data indicate a defective/suppressed 
response in hyperglycemic lungs to respiratory infections.
We have used a mouse model of hyperglycemia (the glucoki-
nase heterozygous knockout model, GK+/-) which exhibit impaired 
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glucose tolerance and diminished insulin secretion in response to 
glucose resulting in raised blood glucose concentration[16,17].
These mice do not exhibit obesity or hyperinsulinemia that is asso-
ciated with the leptin and leptin receptor deficient models of type II 
diabetes such as the ob/ob and db/db mouse[18,19].In this mouse, 
and similar to our findings in vivo and in vitro, raised blood glucose 
is associated with increased glucose in Bronchoalveolar Lavage 
Fluid / Airway Surface Liquid (BALF / ASL ) and there is a posi-
tive relationship between blood glucose concentration and glucose 
in BALF. It is difficult to calculate the volume of mouse lung ASL 
and thus the absolute concentration of glucose without using dilu-
tion markers. However, a mouse of the weight used in these exper-
iments would likely have a surface area of 70cm2[20,21]. Airway 
surface liquid has been proposed to be a depth of 8-35m epend-
ing on the radius of the airway [21,22] and alveolar fluid depths 
are much smaller at 0.1m [23]. A contribution of 50:50 alveolar: 
airway surface liquid to BALF glucose would give an estimate of 
0.48mM glucose in ASL from WT mice and 1.5mM in GK+/- mice. 
Even if it is assumed that most of the sampling is from the distal 
lung i.e. 90:10 alveolar: airway, the resultant glucose concentra-
tions are still calculated to be significantly less than corresponding 
blood glucose in accordance with our previous in vivo and in vitro 
studies [3,9].
Treatment of mice with LPS induced a robust inflamma-
tory response as indicated by the elevation in inflammatory cells 
and pro-inflammatory cytokines in the BALF. Inflammatory cell 
numbers after LPS challenge were similar in GK+/- compared to 
WT mice except for eosinophils which were reduced. Similarly, 
eosinophils but not neutrophils, were reduced in ovalbumin chal-
lenged lungs of diabetic ob/ob mice[24]. No difference in lung 
neutrophils was shown in diabetic Zucker rat lungs after tracheal 
instillation of LPS or in diabetic Wistar rats compared to wildtype 
[12,13]. Thus, hyperglycemia appears to effect eosinophil recruit-
ment to the lung.
LPS challenge decreased BALF glucose over 48 hours. Al-
though, blood glucose declined with the inflammatory response 
[25] this was unlikely to be the cause of the change in BALF glu-
cose as the relationship between blood and BALF glucose was lost 
and BALF glucose concentrations were much lower than expected 
for the corresponding blood glucose after LPS treatment. There 
was however, a clear inverse relationship between glucose con-
centration and number of inflammatory cells/lactate in BALF. A 
previous study in rats showed that tracheal instillation of LPS in-
creased glucose utilization by White Blood Cells (WBC) in the 
airways[26]. This was mostly explained by increased numbers of 
neutrophils which had high glucose utilization and a doubling of 
glucose utilization by activated macrophages[26]. In our study, 
neutrophils and macrophages were the predominant cells post LPS 
treatment. In rats, glucose utilization by activated macrophages and 
PMNs increased to ~7.5 and 1.75nmols/min/106 cells, respectively. 
We had approximately 2 x 106 macrophages plus neutrophils in 
the mouse BALF 48 hours after LPS treatment. If rat and mouse 
models are similar, then glucose utilization would be ~18nmole/
min. WT BALF contained 35nmoles of glucose which would be 
depleted rapidly by LPS activated inflammatory cells. Thus, uti-
lization of glucose by inflammatory cells would account for the 
reduced glucose concentration in the BALF after LPS challenge. 
This hypothesis now needs to be tested to establish if this is indeed 
the case.
Glucose remained detectable in the BALF (except in WT 
24 hours’ post LPS treatment) and glucose concentrations were 
persistently higher in GK+/- mice. We previously showed that LPS 
increased glucose permeability across ex vivo mouse trachea and 
in vitro which would increase glucose diffusion into ASL[9]. We 
therefore suggest that glucose in ASL is metabolized by inflam-
matory cells and that increased glucose permeability during the 
inflammatory response increases glucose diffusion into ASL and 
this process may help sustain inflammatory cell function. During 
hyperglycemia, the increased gradient for glucose diffusion would 
drive even more glucose into ASL resulting in the higher residual 
BALF glucose we observed after LPS treatment in GK+/- mice.
The increase in inflammatory cells correlated with elevation 
of pro-inflammatory cytokines and lactate. Lactate is involved in 
inflammatory cell signaling and is released at sites of inflamma-
tion by activated inflammatory cells. Its production is dependent 
on cellular glucose metabolism by inflammatory cells such as 
neutrophils[27-29]. However, we also observed a small increase 
in BALF lactate (but not in cytokines or inflammatory cells) in 
untreated GK+/- compared to WT mice. We have evidence that hy-
perglycemia elevates epithelial lactate secretion. This may there-
fore reflect a contribution from airway epithelial cells to lactate in 
BALF[8,30-32].
Here we provide evidence that LPS elevated lactate concen-
tration in the BALF of GK+/- mice was reduced compared to WT. 
Consistent with our results, peritoneal neutrophils from streptozo-
tocin-treated diabetic rats exhibited reduced lactate production[33]. 
In these neutrophils, the effect was reversed by insulin treatment. 
Insulin has also been shown to alter other LPS-induced inflam-
matory responses in diabetic rats[34], yet the GK+/- mice used in 
this, and two other studies, had normal circulating plasma insulin 
levels[14,16]. Thus, the role of luminal glucose concentration and 
insulin on inflammatory cell responses in these mice and in the 
lung, needs further investigation.
LPS-treated GK+/- mice also exhibited decreased TNFα, IL-1β and 
IL-2 in the BALF compared to WT. Lower levels of TNFα and 
IL-1β were reported 4-6 hours after LPS challenge also in diabetic 
Wistar rats compared to WT[13,35]. Similar to our findings, in one 
study this was independent of changes in neutrophils although in 
the other, this was not the case[13,35]. TNFα and IL-1β are se-
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creted by activated macrophages. Whilst, we did not see a sig-
nificant reduction of macrophages in BALF, there is evidence that 
macrophage secretory function was impaired in LPS-challenged 
streptozotocin-induced diabetic mice[36].
IL-2 is secreted by αβT-cells which are involved in endo-
toxin-induced airway inflammation[37]. We cannot explain why 
IL-2 was reduced in the GK+/- mice after LPS treatment. Genes in-
volved in IL-2 signaling are implicated in the development of type 
I diabetes and circulating levels are reduced in this disease[38]. We 
did not measure plasma IL-2 and so cannot confirm whether this 
was the case in GK+/- mice. IL-2 is further involved in modifying 
cytokine secretion from other inflammatory cells. For example, 
human airway macrophages can be induced to produce TNFα 
in response to IL-2[39]. In addition, eosinophil degranulation is 
thought to be triggered by IL-2[38]. Thus, it is possible that the 
reduction of IL-2 in LPS-treated GK+/- mice leads to the reduction 
in the secretion of other cytokines and reduced eosinophil numbers 
at 24 hours.
Conclusion
Taken together, we show that acute LPS challenge in the 
mouse lung results in a reduction of BALF glucose concentration 
and elevation of inflammatory cells but that there is altered inflam-
matory cell responses in the lungs of GK+/- mice. We propose that 
glucose in the lung lumen is utilized by inflammatory cells during 
the inflammatory response. We showed previously that hypergly-
cemia results in elevated ASL glucose and that this promotes the 
growth of respiratory pathogens in the lung. We also proposed a 
model for glucose homeostasis across the airway [7,9,30,40]. We 
now propose a more complex model whereby, during infection, 
the inflammatory response competes with the airway epithelium 
and bacteria for glucose in the in the lung. Hyperglycemia elevates 
glucose concentration in the lung lumen resulting in a bigger nutri-
ent pool and an altered immune response. Recent findings in the 
upper airway also showed that glucose in the airway surface liquid 
may suppress anti-microbial peptide secretion[41,42]. Thus, the 
balance that favors neutralization of pathogens in normal lungs 
may shift to favor pathogen evasion/survival in lungs exposed to 
hyperglycemia. Such changes may underlie the increased suscepti-
bility to infection in patients with respiratory disease and diabetes 
(COPD/CF).
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